logo

For the Inventor, By the Inventor

Lexington, MA, United States of America

Indevus Pharmaceuticals, Inc.


USPTO Granted Patents = 13

% Expired Patents = 61.5


Trademarks = 4

Forward Citations = 79

Loading Chart...
Loading Chart...

21 inventors (with patents filed for the assignee):

goldMedal Sandra Marie Jennings (3 out of 3 patents)

silverMedal Thomas Joel Zupancic (3 out of 17 patents)

bronzeMedal Joseph Cioffi (3 out of 12 patents)

4.  Alan Wayne Shafer (3 out of 12 patents)

5.  Timothy L Stuk (3 out of 28 patents)

6.  H Ralph Snodgrass (3 out of 22 patents)

7.  Petr Kuzma (2 out of 22 patents)

8.  Cathryn M Clary (2 out of 2 patents)

9.  Jeroen Van Beek (2 out of 2 patents)

10.  Perry S Eisman (2 out of 2 patents)

11.  Sean Donevan (2 out of 3 patents)

12.  Atul Pande (2 out of 2 patents)

13.  Richard Kavoussi (2 out of 2 patents)

14.  Lyou-Fu Ma (2 out of 2 patents)

15.  Robert B Zurier (2 out of 4 patents)


13 patents:

1. 7842303 - Long term drug delivery devices with polyurethane based polymers and their manufacture (2010-11-30),
2. 7553847 - Use of pagoclone for the treatment of social anxiety disorder (2009-06-30),
3. 7452868 - Controlled release formulations of octreotide (2008-11-18),
4. 7304158 - Method for making 2-(7-chloro-1,8-naphthyridine-2-yl)-3-(5-methyl-2-oxo-hexyl)-1-isoindolinone) (2007-12-04),
5. 7057047 - Methods for making 2-(7-chloro-1,8-naphthyridine-2-yl)-3-(5-methyl-2oxo-hexyl)-1-isoidolinone (2006-06-06),
6. 7026332 - Methods of treating obsessive-compulsive disorder (2006-04-11),
7. 6974835 - Methods for decreasing cell proliferation based on (3r,4r)-Δ8-tetrahydrocannabinol-11-oic acids (2005-12-13),
8. 6953670 - Methods for identifying compounds capable of supplementing the biological activity of leptin (2005-10-11),
9. 6949653 - Methods for making 2-(7-chloro-1,8-naphthyridine-2-yl)-3-(5-methyl-2-oxo-hexyl)-1-isoindolinone (2005-09-27),
10. 6914072 - Cannabinoid drugs (2005-07-05),
11. 6855721 - Methods and compositions for alleviating stuttering (2005-02-15),
12. 6838079 - Methods for using the obese product to stimulate hematopoietic development (2005-01-04),
13. 6524806 - Methods of screening for ligands of human hemetopoietin receptor HU-B1.219 (2003-02-25),
Company Overview
Indevus Pharmaceuticals, Inc. is a biopharmaceutical company based in Lexington, Massachusetts, specializing in the development of innovative therapies for various medical conditions. The organization focuses on advancing treatments primarily in the fields of endocrinology and urology, leveraging its expertise in drug formulation and delivery systems. Indevus is committed to addressing unmet medical needs through its research initiatives, aiming to improve patient outcomes with effective and safe therapeutic options.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

13 Patents

#53 in Lexington, MA

#1,441 in Massachusetts

#23,815 in US

#44,988 in the World

Lexington, MA (US)
Lexington, MA, United States of America

Indevus Pharmaceuticals, Inc.

Forward Citations = 79

21 inventors:

goldMedal Sandra Marie Jennings (3 out of 3 patents)

silverMedal Thomas Joel Zupancic (3 out of 17 patents)

bronzeMedal Joseph Cioffi (3 out of 12 patents)

4.  Alan Wayne Shafer (3 out of 12 patents)

5.  Timothy L Stuk (3 out of 28 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Indevus Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/indevus-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…